Skip to main content

waypoint wealth counsel

SEC CIK
0001807909
Latest filing
Aug 4, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by waypoint wealth counsel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
777
Value
$484.5K
% of portfolio
0.3%
Quarters held
4
Since Q3 2025
Holdings of REGN by waypoint wealth counsel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026777$484.5K0.3%−308−28.4%ReducedHolders
Q1 20261,085$838.3K0.4%+3+0.3%AddedHolders
Q4 20251,082$835.2K0.3%+106+10.9%AddedHolders
Q3 2025976$548.8K0.2%+976NewHolders